CACI Proprietary Information CACI International Inc Q2 FY22 Earnings Conference Call January 27, 2022 CACI Proprietary Information -- 1 of 18 -- 2 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call There are statements made herein that do not address historical facts and, therefore, could be interpreted to be forward- looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to risk factors that could cause actual results to be materially different from anticipated results. These risk factors include, but are not limited to, the following: our reliance on U.S. government contracts, which includes general risk around the government contract procurement process (such as bid protest, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities, such as for homeland security or to address global pandemics like COVID-19; legal, regulatory, and political change from successive presidential administrations that could result in economic uncertainty; changes in U.S. federal agencies, current agreements with other nations, foreign events, or any other events which may affect the global economy, including the impact of global pandemics like COVID-19; the results of government audits and reviews conducted by the Defense Contract Audit Agency, the Defense Contract Management Agency, or other governmental entities with cognizant oversight; competitive factors such as pricing pressures and/or competition to hire and retain employees (particularly those with security clearances); failure to achieve contract awards in connection with re-competes for present business and/or competition for new business; regional and national economic conditions in the United States and globally, including but not limited to: terrorist activities or war, changes in interest rates, currency fluctuations, significant fluctuations in the equity markets, and market speculation regarding our continued independence; our ability to meet contractual performance obligations, including technologically complex obligations dependent on factors not wholly within our control; limited access to certain facilities required for us to perform our work, including during a global pandemic like COVID-19; changes in tax law, the interpretation of associated rules and regulations, or any other events impacting our effective tax rate; changes in technology; the potential impact of the announcement or consummation of a proposed transaction and our ability to successfully integrate the operations of our recent and any future acquisitions; our ability to achieve the objectives of near term or long-term business plans; the effects of health epidemics, pandemics and similar outbreaks may have material adverse effects on our business, financial position, results of operations and/or cash flows; and other risks described in our Securities and Exchange Commission filings. Forward-looking Statements -- 2 of 18 -- 3 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call On Today’s Call John Mengucci President and Chief Executive Officer Thomas Mutryn Chief Financial Officer -- 3 of 18 -- 4 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Revenue +1.2% as reported, ~1% organic Technology revenue +9% Adjusted EBITDA Margin 10.6%1 Robust free cash flow of $117 million1 Strong contract awards of $2.0 billion; ~70% new business to CACI Trailing twelve months (TTM) book-to-bill 1.6x Q2 FY22 Performance 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. -- 4 of 18 -- 5 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Headwinds appeared during Q2 Increase in COVID cases limiting customer engagement and slowing some ramp-ups Slowing pace of task orders, including some Technology Supply chain challenges Modestly reducing FY22 guidance to reflect headwinds continuing in 2H Headwinds are short-term and not impacting customer demand or long-term growth opportunities Budget and Market Environment -- 5 of 18 -- 6 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Contract awards of $2.0 billion include nearly $600 million of unannounced classified contracts Cyber, Electromagnetic Spectrum, and Software-defined Technology Enabled by both organic investments and M&A Classified awards include a multi-hundred million sole-source renewal, new business wins, and expansion of existing work Continue to see good demand for network and digital application modernization Strong Awards -- 6 of 18 -- 7 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Continue to invest ahead of need and deploy capital to drive long-term shareholder value Acquired two Technology companies in Q2 SA Photonics Photonics technologies for free space optical communications (“laser comms”) Combination with CACI creates THE leading U.S.-based photonics provider ID Technologies Technology addressing NSA’s Commercial Solutions for Classified (CSfC), enabling networking modernization and secure remote access Complements CACI’s existing network modernization capabilities Capital Deployment -- 7 of 18 -- 8 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Q2 Financial Summary $4.18 $3.83 $0.00 $1.00 $2.00 $3.00 $4.00 $5.00 Q2 FY21 Q2 FY22 Diluted EPS (GAAP) $1,469 $1,486 $1,200 $1,300 $1,400 $1,500 $1,600 Q2 FY21 Q2 FY22 Revenue (Ms) Organic revenue growth of ~1% Technology revenue +9% Adjusted EBITDA Margin of 10.6%1 +1% -8% 1 See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. $4.69 $4.39 $0.00 $1.00 $2.00 $3.00 $4.00 $5.00 $6.00 Q2 FY21 Q2 FY22 Adjusted Diluted EPS1 -6% -- 8 of 18 -- 9 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Strong Cash Flow $0 $50 $100 $150 $200 $250 $300 $350 $400 $450 $500 $550 $600 $650 $700 Cash Flow1 and CapEx (millions, TTM) Cash Flow from Operations excl. MARPA Capital Expenditures (CapEx) 1 Excludes CACI’s Master Accounts Receivable Purchase Agreement (MARPA). FY20 includes CARES Act payroll tax deferral benefit of ~$41 million. FY21 includes CARES Act payroll tax deferral benefit of ~$53 million and tax payment of ~$90 million due to certain tax elections. FY22E includes estimated tax benefits of ~$230 million and repayment of payroll tax deferral of ~$47 million. See slides at the end of this presentation for definitions and reconciliations of non-GAAP measures. 1 $0.00 $5.00 $10.00 $15.00 $20.00 $25.00 $30.00 $35.00 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22E Free Cash Flow (FCF) per Share1 FY15 to FY20 FY16 to FY21 FY17 to FY22E 5-Year CAGR 14.9% 19.2% 26.2% FY22E is based on guidance provided on January 26, 2022. Investors are reminded that actual results may differ from these estimates for reasons described in the Company’s Safe Harbor Statement and filings with the SEC. -- 9 of 18 -- 10 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Acquired two Technology companies Total consideration ~$500 million FY22 expected revenue contribution ~$120 million SA Photonics ~$25 million in revenue IDT ~$95 million in revenue Both businesses investing to support significant future growth Investments expected to reduce FY22 Adjusted EBITDA margin by 10 basis points Deploying Capital for Growth – Q2 Acquisitions -- 10 of 18 -- 11 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Updating FY22 Guidance FY22 Guidance Revenue (millions) $6,300 – $6,400 Adjusted Net Income1 (millions) $430 – $440 Adjusted Diluted EPS1 $18.14 – $18.57 Free Cash Flow1 (millions) At least $720 (1) For additional information regarding non-GAAP measures, please see the related explanation and reconciliation slides at the end of this presentation. This guidance represents CACI views as of January 26, 2022. Investors are reminded that actual results may differ from these estimates for reasons described in the Company’s Safe Harbor Statement and filings with the SEC. Organic revenue growth of ~2.5% at the midpoint, incl. Afghanistan headwind (2%) Adj. EBITDA Margin1 of ~10.7% (incl. 10 bps impact from acquisitions) Depreciation & amortization of ~$142 million Diluted shares outstanding expected to be ~23.7 million Capital expenditures of ~$90 million -- 11 of 18 -- 12 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Positive Forward Indicators 93% Existing Business STRONG Performance 4% Recompetes HIGH Win Rate 3% New Business QUALITY Pipeline Strong Q2 FY22 contract awards of $2.0 billion TTM Book-to-Bill of 1.6x Backlog of $24.1 billion, +8% YoY Pipeline of submitted bids: $7.0 billion ~80% for new business to CACI Bids expected to be submitted in the next two quarters: $16.7 billion >80% for new business to CACI -- 12 of 18 -- 13 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Delivering solid organic growth, healthy margins, and robust cash flow Near-term headwinds do not change significant long-term growth opportunities Investing ahead of customer need drives strong awards and growing backlog CACI positioned to generate long-term growth, margin expansion, free cash flow per share, and shareholder value Our talented, innovative, diverse employees committed to success Continuing to Execute -- 13 of 18 -- 14 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Adjusted net income and Adjusted diluted EPS are non-GAAP performance measures. We define Adjusted net income and Adjusted diluted EPS as GAAP net income and GAAP diluted EPS, respectively, excluding intangible amortization expense and the related tax impact as we do not consider intangible amortization expense to be indicative of our core operating performance. We believe that these performance measures provide management and investors with useful information in assessing trends in our ongoing operating performance, provide greater visibility in understanding the long-term financial performance of the Company, and allow investors to more easily compare our results to results of our peers. These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in accordance with GAAP. The Company views Adjusted EBITDA and Adjusted EBITDA margin, both of which are defined as non-GAAP measures, as important indicators of performance, consistent with the manner in which management measures and forecasts the Company’s performance. Adjusted EBITDA is a commonly used non-GAAP measure when comparing our results with those of other companies. We define Adjusted EBITDA as GAAP net income plus net interest expense, income taxes, depreciation and amortization expense (including depreciation within direct costs), and earnout adjustments. We consider Adjusted EBITDA to be a useful metric for management and investors to evaluate and compare the ongoing operating performance of our business on a consistent basis across reporting periods, as it eliminates the effect of non-cash items such as depreciation of tangible assets, amortization of intangible assets primarily recognized in business combinations, as well as the effect of earnout gains and losses, which we do not believe are indicative of our core operating performance. Adjusted EBITDA margin is adjusted EBITDA divided by revenue. These non-GAAP measures should not be considered in isolation or as a substitute for performance measures prepared in accordance with GAAP. The Company defines Net cash provided by operating activities excluding MARPA, a non-GAAP measure, as net cash provided by operating activities calculated in accordance with GAAP, adjusted to exclude cash flows from CACI’s Master Accounts Receivable Purchase Agreement (MARPA) for the sale of certain designated eligible U.S. government receivables up to a maximum amount of $200.0 million. Free cash flow is a non-GAAP liquidity measure and may not be comparable to similarly titled measures used by other companies. The Company defines Free cash flow as Net cash provided by operating activities excluding MARPA, less payments for capital expenditures. Free cash flow per share is computed by dividing free cash flow, as defined here, by the diluted weighted average number of common shares outstanding. The Company uses these non-GAAP measures to assess our ability to generate cash from our business operations and plan for future operating and capital actions. We believe this measure allows investors to more easily compare current period results to prior period results and to results of our peers. Free cash flow does not represent residual cash flows available for discretionary purposes and should not be used as a substitute for cash flow measures prepared in accordance with GAAP. These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. Definitions of Non-GAAP Measures -- 14 of 18 -- 15 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Reconciliation of Net Income to Adjusted Net Income and Diluted EPS to Adjusted Diluted EPS (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands, except per share data) 12/31/2021 12/31/2020 % Change 12/31/2021 12/31/2020 % Change Net income, as reported 90,299 $ 106,478 $ -15.2% 178,408 $ 200,122 $ -10.9% Intangible amortization expense 18,054 17,478 3.3% 35,647 33,612 6.1% Tax effect of intangible amortization1 (4,747) (4,595) 3.3% (9,373) (8,838) 6.1% Adjusted net income 103,606 $ 119,361 $ -13.2% 204,682 $ 224,896 $ -9.0% 12/31/2021 12/31/2020 % Change 12/31/2021 12/31/2020 % Change Diluted EPS, as reported 3.83 $ 4.18 $ -8.4% 7.52 $ 7.86 $ -4.3% Intangible amortization expense 0.77 0.69 11.6% 1.50 1.32 13.6% Tax effect of intangible amortization1 (0.21) (0.18) 16.7% (0.39) (0.35) 11.4% Adjusted diluted EPS 4.39 $ 4.69 $ -6.4% 8.63 $ 8.83 $ -2.3% (in millions, except per share amounts) Low End High End Net income, as reported 375 $ --- 385 $ Intangible amortization expense 74 --- 74 Tax effect of intangible amortization1 (20) --- (20) Adjusted net income 430 $ --- 440 $ Low End High End Diluted EPS, as reported 15.83 $ --- 16.26 $ Intangible amortization expense 3.13 --- 3.13 Tax effect of intangible amortization1 (0.82) --- (0.82) Adjusted diluted EPS 18.14 $ --- 18.57 $ (1) Calculation uses an assumed statutory tax rate of 26.3% on non-GAAP tax deductible adjustments. Note: Numbers may not sum due to rounding. FY22 Guidance Range FY22 Guidance Range Three Months Ended Six Months Ended Three Months Ended Six Months Ended -- 15 of 18 -- 16 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands) 12/31/2021 12/31/2020 % Change 12/31/2021 12/31/2020 % Change Net income 90,299 $ 106,478 $ -15.2% 178,408 $ 200,122 $ -10.9% Plus: Income taxes 22,799 25,974 -12.2% 51,321 56,774 -9.6% Interest income and expense, net 11,009 9,087 21.2% 21,407 19,067 12.3% Depreciation and amortization expense, including amounts within direct costs 33,918 33,041 2.7% 67,829 64,053 5.9% Adjusted EBITDA 158,025 $ 174,580 $ -9.5% 318,965 $ 340,016 $ -6.2% (in thousands) 12/31/2021 12/31/2020 % Change 12/31/2021 12/31/2020 % Change Revenues, as reported 1,485,778 $ 1,468,711 $ 1.2% 2,976,676 $ 2,928,217 $ 1.7% Adjusted EBITDA 158,025 174,580 -9.5% 318,965 340,016 -6.2% Adjusted EBITDA margin 10.6% 11.9% 10.7% 11.6% Three Months Ended Six Months Ended Three Months Ended Six Months Ended -- 16 of 18 -- 17 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Reconciliation of Net Cash Provided by Operating Activities to Net Cash Provided by Operating Activities Excluding MARPA and to Free Cash Flow (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands) 12/31/2021 12/31/2020 12/31/2021 12/31/2020 Net cash provided by operating activities 122,812 $ 205,387 $ 308,765 $ 382,287 $ Cash used in (provided by) MARPA 6,038 (15,553) (5,451) 242 Net cash provided by operating activities excluding MARPA 128,850 189,834 303,314 382,529 Capital expenditures (11,429) (15,591) (21,632) (31,873) Free cash flow 117,421 $ 174,243 $ 281,682 $ 350,656 $ (in millions) FY22 Guidance Net cash provided by operating activities1 810 $ Cash used in (provided by) MARPA - Net cash provided by operating activities excluding MARPA 810 Capital expenditures (90) Free cash flow 720 $ Three Months Ended Six Months Ended (1) Includes estimated tax benefits of $230 million related to certain tax elections, as well as payroll tax deferral repayment of approximately $47 million. -- 17 of 18 -- 18 | CACI Proprietary Information CACI Q2 FY22 Earnings Conference Call Reconciliation of Net Cash Provided by Operating Activities to Net Cash Provided by Operating Activities Excluding MARPA, to Free Cash Flow, and to Free Cash Flow per share (Unaudited) These non-GAAP measures should not be considered in isolation or as a substitute for financial measures prepared in accordance with GAAP. (in thousands, except per share data) 6/30/2014 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 (E) Net cash provided by operating activities 203,470 $ 226,862 $ 242,577 $ 281,250 $ 321,460 $ 555,297 $ 518,705 $ 592,215 $ 810,000 $ Cash used in (provided by) MARPA - - - - - (192,527) (7,473) 17,973 - Net cash provided by operating activities excluding MARPA 203,470 226,862 242,577 281,250 321,460 362,770 511,232 610,188 810,000 Capital expenditures (15,279) (17,444) (20,835) (43,268) (41,594) (47,902) (72,303) (73,129) (90,000) Free cash flow 188,191 $ 209,418 $ 221,742 $ 237,982 $ 279,866 $ 314,868 $ 438,929 $ 537,059 $ 720,000 $ Diluted weighted average shares outstanding 25,155 24,388 24,802 25,069 25,255 25,395 25,485 24,992 23,700 Free cash flow per share 7.48 $ 8.59 $ 8.94 $ 9.49 $ 11.08 $ 12.40 $ 17.22 $ 21.49 $ 30.38 $ 5-Year CAGR 10.6% 14.9% 19.2% 26.2% Note: 6/30/2022 (E) reflects estimate for fiscal year 2022 based on financial guidance provided. Twelve Months Ended -- 18 of 18 --